A phase II study of bevacizumab, oxaliplatin, and capecitabine in patients with previously untreated metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study Group.
about
Role of targeted therapy in metastatic colorectal cancerCapecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer.Lack of anti-tumor activity by anti-VEGF treatments in hepatic hemangiomas.Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open-label, single-arm, noncomparative trial.
P2860
A phase II study of bevacizumab, oxaliplatin, and capecitabine in patients with previously untreated metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study Group.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A phase II study of bevacizuma ...... the Korean Cancer Study Group.
@ast
A phase II study of bevacizuma ...... the Korean Cancer Study Group.
@en
type
label
A phase II study of bevacizuma ...... the Korean Cancer Study Group.
@ast
A phase II study of bevacizuma ...... the Korean Cancer Study Group.
@en
prefLabel
A phase II study of bevacizuma ...... the Korean Cancer Study Group.
@ast
A phase II study of bevacizuma ...... the Korean Cancer Study Group.
@en
P2093
P921
P1476
A phase II study of bevacizuma ...... the Korean Cancer Study Group.
@en
P2093
Jae-Lyun Lee
Jee Hyun Kim
Joong Bae Ahn
Kyu-pyo Kim
Kyung Hae Jung
Sang Joon Shin
Seock-Ah Im
Sung Sook Lee
Tae Won Kim
Tae-You Kim
P356
10.1097/COC.0B013E31826B9C94
P577
2014-02-01T00:00:00Z